|
CALCIUM SALTS INTERFERE WITH ITS ABSORPTION FROM THE GUT
|
CO-ADMINISTRATION WITH IRON-CONTAINING PREPARATIONS MAY IMPAIR ORAL ABSORPTION OF TETRACYCLINES
|
CONCURRENT USE MAY RENDER ORAL CONTRACEPTIVE LESS EFFECTIVE
|
CYCLOSPORINE PLASMA LEVELS ARE INCREASED BY THE DRUG
|
ORAL CONTRACEPTIVES EFFICACY IS REDUCED
|
CONCURRENT USE MAY RENDER ORAL CONTRACEPTIVE LESS EFFECTIVE
|
CALCIUM SALTS INTERFERE WITH ITS ABSORPTION FROM THE GUT
|
CONCURRENT USE MAY RENDER ORAL CONTRACEPTIVE LESS EFFECTIVE
|
CO-ADMINISTRATION WITH TETRACYCLINES MAY INCREASE DIGOXIN ABSORPTION IN PATIENTS WITH INACTIVATE DIGOXIN BY BACTERIAL METABOLISM IN THE LOWER INTESTINE, SO THAT DIGITALIS INTOXICATION MAY RESULT
|
CO-ADMINISTRATION WITH ANTACIDS CONTAINING ALUMINUM, MAGNESIUM, AND CALCIUM MAY IMPAIR ORAL ABSORPTION OF TETRACYCLINES
|
ORAL CONTRACEPTIVES EFFICACY IS REDUCED
|
CONCURRENT USE MAY RENDER ORAL CONTRACEPTIVE LESS EFFECTIVE
|
CONCURRENT USE MAY RENDER ORAL CONTRACEPTIVE LESS EFFECTIVE
|
CONCURRENT USE MAY RENDER ORAL CONTRACEPTIVE LESS EFFECTIVE
|
CONCURRENT USE MAY RENDER ORAL CONTRACEPTIVE LESS EFFECTIVE
|
CONCURRENT USE MAY RENDER ORAL CONTRACEPTIVE LESS EFFECTIVE
|
CONCURRENT USE MAY RENDER ORAL CONTRACEPTIVE LESS EFFECTIVE
|
DECREASES THE HALF-LIFE OF DOXYCYCLINE
|
ORAL CONTRACEPTIVES EFFICACY IS REDUCED
|
CONCURRENT USE MAY RENDER ORAL CONTRACEPTIVE LESS EFFECTIVE
|
ORAL IRON PRODUCTS INTERFERE WITH ABSORPTION OF ORAL TETRACYCLINES ; THESE PRODUTCS SHOULD NOT BE TAKEN WITHIN TWO HOURS OF EACH OTHER
|
CO-ADMINISTRATION WITH IRON-CONTAINING PREPARATIONS MAY IMPAIR ORAL ABSORPTION OF TETRACYCLINES
|
ORAL IRON PRODUCTS INTERFERE WITH ABSORPTION OF ORAL TETRACYCLINES ; THESE PRODUTCS SHOULD NOT BE TAKEN WITHIN TWO HOURS OF EACH OTHER
|
ORAL IRON PRODUCTS INTERFERE WITH ABSORPTION OF ORAL TETRACYCLINES ; THESE PRODUTCS SHOULD NOT BE TAKEN WITHIN TWO HOURS OF EACH OTHER
|
ORAL IRON PRODUCTS INTERFERE WITH ABSORPTION OF ORAL TETRACYCLINES ; THESE PRODUTCS SHOULD NOT BE TAKEN WITHIN TWO HOURS OF EACH OTHER
|
ORAL IRON PRODUCTS INTERFERE WITH ABSORPTION OF ORAL TETRACYCLINES ; THESE PRODUTCS SHOULD NOT BE TAKEN WITHIN TWO HOURS OF EACH OTHER
|
CO-ADMINISTRATION WITH IRON-CONTAINING PREPARATIONS MAY IMPAIR ORAL ABSORPTION OF TETRACYCLINES
|
ORAL IRON PRODUCTS INTERFERE WITH ABSORPTION OF ORAL TETRACYCLINES ; THESE PRODUTCS SHOULD NOT BE TAKEN WITHIN TWO HOURS OF EACH OTHER
|
CO-ADMINISTRATION WITH IRON-CONTAINING PREPARATIONS MAY IMPAIR ORAL ABSORPTION OF TETRACYCLINES
|
ORAL IRON PRODUCTS INTERFERE WITH ABSORPTION OF ORAL TETRACYCLINES ; THESE PRODUTCS SHOULD NOT BE TAKEN WITHIN TWO HOURS OF EACH OTHER
|
ORAL IRON PRODUCTS INTERFERE WITH ABSORPTION OF ORAL TETRACYCLINES ; THESE PRODUTCS SHOULD NOT BE TAKEN WITHIN TWO HOURS OF EACH OTHER
|
ORAL IRON PRODUCTS INTERFERE WITH ABSORPTION OF ORAL TETRACYCLINES ; THESE PRODUTCS SHOULD NOT BE TAKEN WITHIN TWO HOURS OF EACH OTHER
|
ORAL IRON PRODUCTS INTERFERE WITH ABSORPTION OF ORAL TETRACYCLINES ; THESE PRODUTCS SHOULD NOT BE TAKEN WITHIN TWO HOURS OF EACH OTHER
|
CONCURRENT USE MAY RENDER ORAL CONTRACEPTIVE LESS EFFECTIVE
|
DEPRESSED PLASMA PROTHROMBIN ACTIVITY ; MAY REQUIRE DOWNWARD ADJUSTMENT OF THE ANTICOAGULANT DOSAGE
|
ALCOHOL ACCELERATE THE METABOLISM OF THE DRUG BY LIVER BY INDUCING HEPATIC ENZYMES
|
FOLIC ACID DEFICIENCY MAY PRECIPITATE WITH CONCURRENT USE
|
HYPOGLYCEMIC EFFECT IS POTENTIATED
|
HYPOGLYCEMIC EFFECT IS POTENTIATED
|
HYPOGLYCEMIC EFFECT IS POTENTIATED
|
HYPOGLYCEMIC EFFECT IS POTENTIATED
|
HEPARIN ACTIVITY IS REDUCED BY THE DRUG
|
INSULIN REQUIREMENT IS DECREASED BY THE DRUG
|
INSULIN REQUIREMENT IS DECREASED BY THE DRUG
|
INSULIN REQUIREMENT IS DECREASED BY THE DRUG
|
INSULIN REQUIREMENT IS DECREASED BY THE DRUG
|
INSULIN REQUIREMENT IS DECREASED BY THE DRUG
|
INSULIN REQUIREMENT IS DECREASED BY THE DRUG
|
THIAZIDE DIURETICS CONCOMITANT USE MAY LEAD TO TOXIC BLOOD LEVELS OF THE DRUG
|
THIAZIDE DIURETICS CONCOMITANT USE MAY LEAD TO TOXIC BLOOD LEVELS OF THE DRUG
|
ORAL CONTRACEPTIVES EFFICACY IS REDUCED
|
CONCURRENT USE MAY RENDER ORAL CONTRACEPTIVE LESS EFFECTIVE
|
CALCIUM SALTS INTERFERE WITH ITS ABSORPTION FROM THE GUT
|
THIAZIDE DIURETICS CONCOMITANT USE MAY LEAD TO TOXIC BLOOD LEVELS OF THE DRUG
|
INSULIN REQUIREMENT IS DECREASED BY THE DRUG
|
CO-ADMINISTRATION WITH IRON-CONTAINING PREPARATIONS MAY IMPAIR ORAL ABSORPTION OF TETRACYCLINES
|
ORAL IRON PRODUCTS INTERFERE WITH ABSORPTION OF ORAL TETRACYCLINES ; THESE PRODUTCS SHOULD NOT BE TAKEN WITHIN TWO HOURS OF EACH OTHER
|
CO-ADMINISTRATION WITH IRON-CONTAINING PREPARATIONS MAY IMPAIR ORAL ABSORPTION OF TETRACYCLINES
|
ORAL IRON PRODUCTS INTERFERE WITH ABSORPTION OF ORAL TETRACYCLINES ; THESE PRODUTCS SHOULD NOT BE TAKEN WITHIN TWO HOURS OF EACH OTHER
|
ORAL IRON PRODUCTS INTERFERE WITH ABSORPTION OF ORAL TETRACYCLINES ; THESE PRODUTCS SHOULD NOT BE TAKEN WITHIN TWO HOURS OF EACH OTHER
|
CO-ADMINISTRATION WITH IRON-CONTAINING PREPARATIONS MAY IMPAIR ORAL ABSORPTION OF TETRACYCLINES
|
ORAL IRON PRODUCTS INTERFERE WITH ABSORPTION OF ORAL TETRACYCLINES ; THESE PRODUTCS SHOULD NOT BE TAKEN WITHIN TWO HOURS OF EACH OTHER
|
CO-ADMINISTRATION WITH IRON-CONTAINING PREPARATIONS MAY IMPAIR ORAL ABSORPTION OF TETRACYCLINES
|
ORAL IRON PRODUCTS INTERFERE WITH ABSORPTION OF ORAL TETRACYCLINES ; THESE PRODUTCS SHOULD NOT BE TAKEN WITHIN TWO HOURS OF EACH OTHER
|
INSULIN REQUIREMENT IS DECREASED BY THE DRUG
|
DECREASES THE HALF-LIFE OF DOXYCYCLINE
|
KAOLIN REDUCES ABSORPTION OF THE DRUG FROM GUT
|
CO-ADMINISTRATION WITH BARBITURATES DECREASES THE HALF-LIFE OF DOXYCYCLINE
|
CO-ADMINISTRATION WITH IRON-CONTAINING PREPARATIONS MAY IMPAIR ORAL ABSORPTION OF TETRACYCLINES
|
CO-ADMINISTRATION WITH ANTACIDS CONTAINING ALUMINUM, MAGNESIUM, AND CALCIUM MAY IMPAIR ORAL ABSORPTION OF TETRACYCLINES
|
CO-ADMINISTRATION WITH ANTACIDS CONTAINING ALUMINUM, MAGNESIUM, AND CALCIUM MAY IMPAIR ORAL ABSORPTION OF TETRACYCLINES
|
BACTERIOSTATICS LIKE TETRACYCLINES MAY INTERFERE WITH BACTERICIDAL EFFECTS OF PENICILLIN ; THIS HAS BEEN DEMONSTRATED IN VITRO, HOWEVER, THE CLINICAL SIGNIFICANCE OF THE INTERACTION IS NOT WELL DOCUMENTED
|
BACTERIOSTATICS LIKE TETRACYCLINES MAY INTERFERE WITH BACTERICIDAL EFFECTS OF PENICILLIN ; THIS HAS BEEN DEMONSTRATED IN VITRO, HOWEVER, THE CLINICAL SIGNIFICANCE OF THE INTERACTION IS NOT WELL DOCUMENTED
|
BACTERIOSTATIC DRUGS MAY INTERFERE WITH BACTERICIDAL ACTION OF PENICILLIN
|
BACTERIOSTATIC DRUGS MAY INTERFERE WITH BACTERICIDAL ACTION OF PENICILLIN
|
THIAZIDE DIURETICS CONCOMITANT USE MAY LEAD TO TOXIC BLOOD LEVELS OF THE DRUG
|
ORAL CONTRACEPTIVES EFFICACY IS REDUCED
|
CONCURRENT USE MAY RENDER ORAL CONTRACEPTIVE LESS EFFECTIVE
|
ORAL CONTRACEPTIVES EFFICACY IS REDUCED
|
CONCURRENT USE MAY RENDER ORAL CONTRACEPTIVE LESS EFFECTIVE
|
CO-ADMINISTRATION WITH ANTACIDS CONTAINING ALUMINUM, MAGNESIUM, AND CALCIUM MAY IMPAIR ORAL ABSORPTION OF TETRACYCLINES
|
CO-ADMINISTRATION WITH ANTACIDS CONTAINING ALUMINUM, MAGNESIUM, AND CALCIUM MAY IMPAIR ORAL ABSORPTION OF TETRACYCLINES
|
CO-ADMINISTRATION WITH ANTACIDS CONTAINING ALUMINUM, MAGNESIUM, AND CALCIUM MAY IMPAIR ORAL ABSORPTION OF TETRACYCLINES
|
CO-ADMINISTRATION WITH ANTACIDS CONTAINING ALUMINUM, MAGNESIUM, AND CALCIUM MAY IMPAIR ORAL ABSORPTION OF TETRACYCLINES
|
CO-ADMINISTRATION WITH ANTACIDS CONTAINING ALUMINUM, MAGNESIUM, AND CALCIUM MAY IMPAIR ORAL ABSORPTION OF TETRACYCLINES
|
CO-ADMINISTRATION WITH ANTACIDS CONTAINING ALUMINUM, MAGNESIUM, AND CALCIUM MAY IMPAIR ORAL ABSORPTION OF TETRACYCLINES
|
ORAL CONTRACEPTIVES EFFICACY IS REDUCED
|
CONCURRENT USE MAY RENDER ORAL CONTRACEPTIVE LESS EFFECTIVE
|
CONCURRENT USE MAY RENDER ORAL CONTRACEPTIVE LESS EFFECTIVE
|
HYPOGLYCEMIC EFFECT IS POTENTIATED
|
POTENTIAL FOR INCREASED MYELOTOXICITY AND NEPHROTOXICITY
|
CALCIUM SALTS INTERFERE WITH ITS ABSORPTION FROM THE GUT
|
MOLYBDENUM IMPAIRES THE ABSORPTION OF THE DRUG
|
INSULIN REQUIREMENT IS DECREASED BY THE DRUG
|
ORAL CONTRACEPTIVES EFFICACY IS REDUCED
|
CONCURRENT USE MAY RENDER ORAL CONTRACEPTIVE LESS EFFECTIVE
|
ORAL CONTRACEPTIVES EFFICACY IS REDUCED
|
CONCURRENT USE MAY RENDER ORAL CONTRACEPTIVE LESS EFFECTIVE
|
ORAL CONTRACEPTIVES EFFICACY IS REDUCED
|
CONCURRENT USE MAY RENDER ORAL CONTRACEPTIVE LESS EFFECTIVE
|